Development of an optimized protocol for NMR metabolomics studies of human colon cancer cell lines and first insight from testing of the protocol using DNA G-quadruplex ligands as novel anti-cancer drugs

Ilaria Lauri; Francesco Savorani; Nunzia Iaccarino; Pasquale Zizza; Luigi Michele Pavone; Ettore Novellino; Søren Balling Engelsen; Antonio Randazzo

doi:10.3390/metabo6010004

Development of an optimized protocol for NMR metabolomics studies of human colon cancer cell lines and first insight from testing of the protocol using DNA G-quadruplex ligands as novel anti-cancer drugs

Ilaria Lauri, Francesco Savorani, Nunzia Iaccarino, Pasquale Zizza, Luigi Michele Pavone, Ettore Novellino, Søren Balling Engelsen, Antonio Randazzo

Food Analytics and Biotechnology

11 Citations (Scopus)

64 Downloads (Pure)

Original language	English
Journal	Metabolites
Volume	6
Issue number	1
Number of pages	14
ISSN	2218-1989
DOIs	https://doi.org/10.3390/metabo6010004
Publication status	Published - 15 Jan 2016

Keywords

cell metabolomics
colon cancer
NMR spectroscopy
Multivariate statistical analysis
G-quadruplex ligands

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/metabo6010004Licence: CC BY

Lauri_2016_Development_of_an_optimizedFinal published version, 1.88 MBLicence: CC BY

Cite this

Lauri, I., Savorani, F., Iaccarino, N., Zizza, P., Pavone, L. M., Novellino, E., Engelsen, S. B., & Randazzo, A. (2016). Development of an optimized protocol for NMR metabolomics studies of human colon cancer cell lines and first insight from testing of the protocol using DNA G-quadruplex ligands as novel anti-cancer drugs. Metabolites, 6(1). https://doi.org/10.3390/metabo6010004

Development of an optimized protocol for NMR metabolomics studies of human colon cancer cell lines and first insight from testing of the protocol using DNA G-quadruplex ligands as novel anti-cancer drugs. / Lauri, Ilaria; Savorani, Francesco; Iaccarino, Nunzia et al.

In: Metabolites, Vol. 6, No. 1, 15.01.2016.

Research output: Contribution to journal › Journal article › Research › peer-review

Lauri, I, Savorani, F, Iaccarino, N, Zizza, P, Pavone, LM, Novellino, E, Engelsen, SB & Randazzo, A 2016, 'Development of an optimized protocol for NMR metabolomics studies of human colon cancer cell lines and first insight from testing of the protocol using DNA G-quadruplex ligands as novel anti-cancer drugs', Metabolites, vol. 6, no. 1. https://doi.org/10.3390/metabo6010004

@article{43d0e3b25a144675a94fd2c80a93fe33,

title = "Development of an optimized protocol for NMR metabolomics studies of human colon cancer cell lines and first insight from testing of the protocol using DNA G-quadruplex ligands as novel anti-cancer drugs",

keywords = "cell metabolomics, colon cancer, NMR spectroscopy, Multivariate statistical analysis, G-quadruplex ligands",

author = "Ilaria Lauri and Francesco Savorani and Nunzia Iaccarino and Pasquale Zizza and Pavone, {Luigi Michele} and Ettore Novellino and Engelsen, {S{\o}ren Balling} and Antonio Randazzo",

year = "2016",

month = jan,

day = "15",

doi = "10.3390/metabo6010004",

language = "English",

volume = "6",

journal = "Metabolites",

issn = "2218-1989",

publisher = "M D P I AG",

number = "1",

}

TY - JOUR

T1 - Development of an optimized protocol for NMR metabolomics studies of human colon cancer cell lines and first insight from testing of the protocol using DNA G-quadruplex ligands as novel anti-cancer drugs

AU - Lauri, Ilaria

AU - Savorani, Francesco

AU - Iaccarino, Nunzia

AU - Zizza, Pasquale

AU - Pavone, Luigi Michele

AU - Novellino, Ettore

AU - Engelsen, Søren Balling

AU - Randazzo, Antonio

PY - 2016/1/15

Y1 - 2016/1/15

KW - cell metabolomics

KW - colon cancer

KW - NMR spectroscopy

KW - Multivariate statistical analysis

KW - G-quadruplex ligands

U2 - 10.3390/metabo6010004

DO - 10.3390/metabo6010004

M3 - Journal article

C2 - 26784246

SN - 2218-1989

VL - 6

JO - Metabolites

JF - Metabolites

IS - 1

ER -

Development of an optimized protocol for NMR metabolomics studies of human colon cancer cell lines and first insight from testing of the protocol using DNA G-quadruplex ligands as novel anti-cancer drugs

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this